Literature DB >> 21521428

Monoamine oxidase A variants are associated with heavy betel quid use.

Ping-Ho Chen1, Hung-Pin Tu, Shu-Jung Wang, Albert Min-Shan Ko, Chi-Pin Lee, Tai-An Chiang, Yi-Shan Tsai, Chien-Hung Lee, Tien-Yu Shieh, Chih-Hung Ko, Shang-Lun Chiang, Ying-Chin Ko.   

Abstract

Few studies have investigated whether genetic abnormalities predispose individuals to heavy betel quid (BQ) use. One of the major ingredients of BQ, arecoline, is known to affect the expression of monoamine oxidase A (MAO-A). We investigated the extent to which arecoline inhibits MAO-A expression and the role of MAO-A polymorphisms in BQ use in Taiwanese aborigines. Cytotoxicity assays, microarrays and quantitative reverse transcriptase-polymerase chain reaction were used to examine the effects of arecoline and areca nut extract (ANE) on cell viability and MAO-A expression in neuroblastoma SH-SY5Y cells. After identifying the effective concentrations of arecoline and ANE in vitro, we examined the in vivo effects of these compounds using a rat model system. Our results indicate that arecoline and ANE inhibit MAO-A expression both in vitro and in vivo. In addition, we examined the correlation between plasma MAO-A activity and cumulative exposure to BQ in humans. We recruited 1307 aborigines from a large-scale community-based survey to determine whether MAO-A variants were associated with high BQ use and a preference for use with smoking or alcohol and whether gender bias existed. MAO-A expression was significantly downregulated by arecoline and ANE at 100-200 µg/ml and in rat whole brains on days 30 and 45. MAO-A activity levels in human plasma were positively correlated with the extent of BQ exposure, and individuals with at-risk alleles exhibited lower activity, although this result did not reach statistical significance. We found two single nucleotide polymorphism (SNPs) in aboriginal males [rs2283725, odds ratio (OR) = 2.04; rs5953210, OR = 2.03] and females (rs2283725, OR = 1.54; rs5953210, OR = 1.59) that were associated with heavy BQ use. Those individuals carrying at-risk alleles who drank alcohol were twice as likely to be heavy BQ users. However, the effects of these SNPs on BQ use were significant even after controlling for alcohol use. Our results suggest that two specific loci may confer a susceptibility to BQ abuse and affect MAO-A enzymatic activity.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521428     DOI: 10.1111/j.1369-1600.2011.00331.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  7 in total

1.  Betel quid: New insights into an ancient addiction.

Authors:  Clare Stokes; Jose A Pino; D Walker Hagan; Gonzalo E Torres; Edward A Phelps; Nicole A Horenstein; Roger L Papke
Journal:  Addict Biol       Date:  2022-09       Impact factor: 4.093

2.  Antidepressants in association with reducing risk of oral cancer occurrence: a nationwide population-based cohort and nested case-control studies.

Authors:  Chia-Min Chung; Tzer-Min Kuo; Shang-Lun Chiang; Zhi-Hong Wang; Chung-Chieh Hung; Hsien-Yuan Lane; Chiu-Shong Liu; Ying-Chin Ko
Journal:  Oncotarget       Date:  2016-03-08

Review 3.  Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers.

Authors:  Ping-Ho Chen; Qaisar Mahmood; Gian Luigi Mariottini; Tai-An Chiang; Ka-Wo Lee
Journal:  Biomed Res Int       Date:  2017-12-11       Impact factor: 3.411

4.  Effect of antidepressants for cessation therapy in betel-quid use disorder: a randomised, double-blind, placebo-controlled trial.

Authors:  Chung-Chieh Hung; Chien-Hung Lee; Albert Min-Shan Ko; Hsien-Yuan Lane; Chi-Pin Lee; Ying-Chin Ko
Journal:  Epidemiol Psychiatr Sci       Date:  2020-05-06       Impact factor: 6.892

5.  Antidepressant-induced reduction in betel-quid use in patients with depression: A pioneer clinical study.

Authors:  Chung-Chieh Hung; Chien-Hung Lee; Chia-Min Chung; Srinivasan Nithiyanantham; Hsien-Yuan Lane; Ying-Chin Ko
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

6.  Sinulariolide Inhibits Gastric Cancer Cell Migration and Invasion through Downregulation of the EMT Process and Suppression of FAK/PI3K/AKT/mTOR and MAPKs Signaling Pathways.

Authors:  Yu-Jen Wu; Shih-Hsiung Lin; Zhong-Hao Din; Jui-Hsin Su; Chih-I Liu
Journal:  Mar Drugs       Date:  2019-11-27       Impact factor: 5.118

7.  Reduction in and Preventive Effects for Oral-Cancer Risk with Antidepressant Treatment.

Authors:  Chia-Min Chung; Tzer-Min Kuo; Kun-Tu Yeh; Chien-Hung Lee; Ying-Chin Ko
Journal:  J Pers Med       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.